What PDCI Market Access does

PDCI Market Access is a Canadian pharmaceutical market access consultancy that advises drug manufacturers on pricing, reimbursement, health technology assessment (HTA), and payer negotiation strategies for the Canadian market. Founded in 1996 and headquartered in Mississauga, Ontario, the firm operates as a service line within McKesson Canada's Specialty Health division, doing business under the "PDCI" and "Insights & Consulting" brands ([email protected], pdci.ca). Its clients are pharmaceutical manufacturers — primarily enterprise biopharma companies bringing innovative therapies to Canadian patients — who require expertise across regulatory planning, evidence generation, dossier development, and stakeholder engagement through the product lifecycle.

The firm's core offering is a single, end-to-end Market Access Consulting engagement that spans strategic launch planning, health economic modeling, value proposition development, payer negotiations, and post-launch lifecycle support. Delivery relies on a small (11-50 employee), highly specialized team applying qualitative and quantitative research methods rather than proprietary software platforms; no AI/ML, API, or productized technology component is disclosed. There are no separately branded sub-products, with the entire value proposition wrapped into one consulting service positioned under McKesson's broader Specialty Health umbrella alongside distribution, patient support, and 3PL services.

Commercially, PDCI operates as a B2B enterprise consulting practice using contact-based quoting for engagements (pricing is not publicly disclosed) and a relationship-driven GTM motion that goes through McKesson Canada's corporate channels, LinkedIn presence, and direct client engagement. The firm operates exclusively in Canada with no international footprint claim. Revenue is not publicly reported as PDCI is a service line within McKesson Canada rather than a standalone reporting entity, and there are no independent funding rounds, M&A activity, named customer logos, or leadership disclosures available in the source data.

Name

PDCI Market Access

Legal name

McKesson Canada

Website

https://pdci.ca

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

11–50 employees

Short description

PDCI Market Access is a Canadian pharmaceutical market access consultancy that advises drug manufacturers on pricing, reimbursement, health technology assessments, and payer negotiations to bring therapies to Canadian patients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Market Access Consulting

SIC

Services-Health Services (8000)

akta.pro primary industry

Regulatory Strategy & IND/NDA/BLA Submissions Support (HLAIALAH)

Keywords

• Pharmaceutical consulting
• Market access services
• Pricing reimbursement
• Health technology assessment
• Payer negotiation

Headquarters

HQ city

Mississauga

HQ country

Canada

HQ region

North America

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Market Access Consulting Services: Professional consulting services provided to pharmaceutical manufacturers seeking market access support in Canada. Services include strategic pricing guidance, health technology assessment support, payer negotiation, reimbursement strategy, and evidence generation throughout the product lifecycle.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

PDCI Market Access is a Canadian pharmaceutical market access consulting service that helps manufacturers bring innovative therapies to Canadian patients. The firm provides strategic pricing guidance, health technology assessment (HTA) support, payer dossier development, reimbursement strategy, payer negotiation, and health economic modeling, delivering end-to-end guidance from regulatory planning through stakeholder engagement to reimbursement across the product lifecycle.

Product overview

PDCI Market Access is a market access consulting service offered by McKesson Canada under its Specialty Health division. It provides a single, unified consulting service focused on helping pharmaceutical manufacturers navigate the complex Canadian market access landscape. The service encompasses strategic pricing, health technology assessments, payer dossier development, and health economic modeling—offering end-to-end guidance from regulatory planning through stakeholder engagement to reimbursement negotiations.

Differentiator

Problem solved

Functional benefit

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves1 record

Expansion highlights2 records

Broad incumbents

• Syneos Health: Large CRO/commercialization services firm with a market access consulting practice. Provides pricing, reimbursement, and HTA advisory alongside broader launch and medical affairs capabilities.
• Cencora (AmerisourceBergen): Pharma distribution and services conglomerate housing Xcenda. Operates in adjacent pharma services space with global reach that contrasts with PDCI's Canada-only scope.
• Charles River Associates: Global consulting firm with a Life Sciences practice providing market access, pricing, and health economics advisory. Competes for similar pharma manufacturer engagements with broader analytical capabilities.
• McKesson Corporation: Parent company of McKesson Canada (PDCI's owner). Operates specialty distribution, pharmacy services, and biopharma services with adjacent market access capabilities through broader strategic partnerships.
• IQVIA: Global life sciences services and market access consulting firm with deep Canadian presence. Offers proprietary data, RWE, and HTA support that competes directly with PDCI's service lines, though at much broader scale.

Direct peers

• Putnam Associates: Life sciences strategy consulting firm focused on market access, pricing, and commercial strategy for pharma and biotech. Comparable boutique model with similar HTA and reimbursement advisory services.
• ClearView Healthcare Partners: Specialist life sciences strategy consultancy with strong market access and health economics practice. Closely comparable boutique model targeting pharma manufacturers on pricing, reimbursement, and HTA strategy.
• Xcenda: Market access and health economics consulting arm of Cencora (formerly AmerisourceBergen). Delivers HTA support, health economic modeling, and payer engagement services directly comparable to PDCI's offering.
• Avalere Health: Healthcare consulting firm with deep market access, pricing, and policy expertise serving pharma and biotech. Provides HTA and payer strategy services that overlap directly with PDCI's core offering.
• EVERSANA: Independent pharma services firm with a dedicated market access and payer solutions practice. Competes head-to-head with PDCI on HTA submissions, pricing strategy, and reimbursement engagements for North American pharma clients.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/PDCImktaccess
• Facebookfacebook.com//mckessonCA
• LinkedInlinkedin.com/company/mckesson-canada
• Instagraminstagram.com/mckessoncanada

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PDCI Market Access